Histone H1.2 Represses the Transcription of the


Journal

Anticancer research
ISSN: 1791-7530
Titre abrégé: Anticancer Res
Pays: Greece
ID NLM: 8102988

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 15 05 2023
revised: 06 06 2023
accepted: 13 06 2023
medline: 31 7 2023
pubmed: 28 7 2023
entrez: 27 7 2023
Statut: ppublish

Résumé

CDK inhibitor p16 plays a pivotal role in the induction of cellular senescence and functions as a tumor suppressor. Here, we demonstrate that histone H1.2 is involved in p16 repression. Cells were transfected with siRNAs and subjected to quantitative reverse transcription-polymerase chain reaction, immunoblotting and chromatin immunoprecipitation (ChIP) assay. The decrease in H1.2 by oncogenic RAS was associated with increased levels of p16. Depletion of H1.2 selectively increased p16, but not alternative reading frame (ARF) mRNA. ChIP assay showed that H1.2 directly bound to the p16 promoter. Interestingly, silencing YB-1, a component of H1.2 complex, decreased the expression levels of H1.2, resulting in decreased binding of H1.2 on the p16 promoter. These results provide a model in which H1.2 is positively regulated by YB-1 and directly binds to and represses the transcription of p16.

Sections du résumé

BACKGROUND/AIM OBJECTIVE
CDK inhibitor p16 plays a pivotal role in the induction of cellular senescence and functions as a tumor suppressor. Here, we demonstrate that histone H1.2 is involved in p16 repression.
MATERIALS AND METHODS METHODS
Cells were transfected with siRNAs and subjected to quantitative reverse transcription-polymerase chain reaction, immunoblotting and chromatin immunoprecipitation (ChIP) assay.
RESULTS RESULTS
The decrease in H1.2 by oncogenic RAS was associated with increased levels of p16. Depletion of H1.2 selectively increased p16, but not alternative reading frame (ARF) mRNA. ChIP assay showed that H1.2 directly bound to the p16 promoter. Interestingly, silencing YB-1, a component of H1.2 complex, decreased the expression levels of H1.2, resulting in decreased binding of H1.2 on the p16 promoter.
CONCLUSION CONCLUSIONS
These results provide a model in which H1.2 is positively regulated by YB-1 and directly binds to and represses the transcription of p16.

Identifiants

pubmed: 37500167
pii: 43/8/3441
doi: 10.21873/anticanres.16519
doi:

Substances chimiques

Histones 0
Cyclin-Dependent Kinase Inhibitor p16 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3441-3446

Informations de copyright

Copyright © 2023 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Auteurs

Yojiro Kotake (Y)

Graduate School of Humanity-Oriented Science and Engineering, Kindai University, Fukuoka, Japan; ykotake@fuk.kindai.ac.jp.
Department of Biological and Environmental Chemistry, Faculty of Humanity-Oriented Science and Engineering, Kindai University, Fukuoka, Japan.

Yoshinobu Tanigawa (Y)

Graduate School of Humanity-Oriented Science and Engineering, Kindai University, Fukuoka, Japan.

Ryoka Tarumi (R)

Graduate School of Humanity-Oriented Science and Engineering, Kindai University, Fukuoka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH